Next Article in Journal
Next Article in Special Issue
Previous Article in Journal
Previous Article in Special Issue
Nutrients 2013, 5(3), 651-662; doi:10.3390/nu5030651
Review

Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy

1,2,*  and 1
Received: 20 December 2012; in revised form: 14 February 2013 / Accepted: 20 February 2013 / Published: 1 March 2013
(This article belongs to the Special Issue Gut Microbiota and Gut Function)
View Full-Text   |   Download PDF [490 KB, uploaded 1 March 2013]   |   Browse Figure
Abstract: Cow’s milk allergy (CMA) continues to be a growing health concern for infants living in Western countries. The long-term prognosis for the majority of affected infants is good, with about 80% naturally acquiring tolerance by the age of four years. However, recent studies suggest that the natural history of CMA is changing, with an increasing persistence until later ages. The pathogenesis of CMA, as well as oral tolerance, is complex and not completely known, although numerous studies implicate gut-associated immunity and enteric microflora, and it has been suggested that an altered composition of intestinal microflora results in an unbalanced local and systemic immune response to food allergens. In addition, there are qualitative and quantitative differences in the composition of gut microbiota between patients affected by CMA and healthy infants. These findings prompt the concept that specific beneficial bacteria from the human intestinal microflora, designated probiotics, could restore intestinal homeostasis and prevent or alleviate allergy, at least in part by interacting with the intestinal immune cells. The aim of this paper is to review what is currently known about the use of probiotics as dietary supplements in CMA.
Keywords: food allergy; probiotics; intestinal microflora; immune system; tolerance acquisition food allergy; probiotics; intestinal microflora; immune system; tolerance acquisition
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Canani, R.B.; Di Costanzo, M. Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy. Nutrients 2013, 5, 651-662.

AMA Style

Canani RB, Di Costanzo M. Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy. Nutrients. 2013; 5(3):651-662.

Chicago/Turabian Style

Canani, Roberto B.; Di Costanzo, Margherita. 2013. "Gut Microbiota as Potential Therapeutic Target for the Treatment of Cow’s Milk Allergy." Nutrients 5, no. 3: 651-662.



Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert